Patient-Reported Outcomes from a 1-Year, Real-World, Head-to-Head Comparison of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine

• Үндсэн зохиолчид: Andrew M. Blumenfeld (Зохиогч), Atul T. Patel (Зохиогч), Ira M. Turner (Зохиогч), Kathleen B. Mullin (Зохиогч), Aubrey Manack Adams (Зохиогч), John F. Rothrock (Зохиогч)
• Формат: Ном
• Хэвлэсэн: SAGE Publishing, 2020-09-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

Introduction/Objective: Chronic migraine (CM) is associated with impaired health-related quality of life and substantial socioeconomic burden, but many people with CM are underdiagnosed and do not receive appropriate preventive treatment. OnabotulinumtoxinA and topiramate have demonstrated efficacy...